Zosano Pharma Corporation ZSAN

$ 0.56 7.23%

Quarterly report 2022-Q1
added 12-23-2023

Zosano Pharma Corporation Financial Statements 2011-2024 | ZSAN

Annual Financial Statements Zosano Pharma Corporation

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	52.7 M	35.8 M	24.9 M	20 M	11.6 M	16.1 M	26 M	129 M	-	-	-
Shares	112 M	67.9 M	16.4 M	9.45 M	1.73 M	689 K	571 K	581 K	-	-	-
Historical Prices	0.47	0.527	1.52	2.12	10.4	15.6	45.6	-	-	-	-
Net Income	-29.9 M	-33.4 M	-37.6 M	-35.4 M	-29.1 M	-29.8 M	-28.4 M	-14.2 M	-5.61 M	1.82 M	-
Revenue	785 K	224	-	-	-	-	313 K	2.86 M	4.25 M	11.6 M	-
Cost of Revenue	796 K	171 K	-	-	-	-	-	-	-	-	-
Gross Profit	-	53	-	-	-	-	313 K	2.76 M	4.25 M	11.6 M	-
Operating Income	-31.5 M	-32.8 M	-37.2 M	-35.4 M	-28.4 M	-28.6 M	-26.4 M	-12.6 M	-	-	-
Interest Expense	189 K	719 K	523 K	379 K	817 K	-7 K	-97 K	-93 K	-	-	-
EBITDA	-29.8 M	-31.3 M	-36.5 M	-34.6 M	-25.8 M	-26.1 M	-23.9 M	-9.57 M	-7.54 M	4.22 M	-
Operating Expenses	-	33 K	37.2 M	34.9 M	28.4 M	28.6 M	26.7 M	15.4 M	12.2 M	8.48 M	-
General and Administrative Expenses	10.5 M	11.2 M	11.8 M	9.36 M	8.18 M	8.18 M	6.32 M	4.42 M	4.58 M	3.08 M	-

All numbers in USD currency

Quarterly Income Statement Zosano Pharma Corporation

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	4.25 M	120 M	116 M	109 M	2.98 M	102 M	77.9 M	54.9 M	54.4 M	23.5 M	17.8 M	16.9 M	12 M	12 M	12 M	11.8 M	1.97 M	1.97 M	39.2 M	39.2 M	1.02 M	841 K	14.3 M	12 M	12 M	12 M	12 M	11.9 M	9.79 M	5.16 M	5.14 M	5.12 M	5.11 M	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-33.4 M	-	-8.67 M	-6.14 M	-8.14 M	-	-8.69 M	-7.9 M	-8.69 M	-	-9.86 M	-9.36 M	-9.43 M	-	-8.17 M	-8.84 M	-8.21 M	-	-7.87 M	-6.75 M	-7 M	-	-7.45 M	-6.52 M	-8.12 M	-	-8.62 M	-7.58 M	-4.58 M	-	-3.68 M	-3.91 M	-2.37 M	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	132 K	-	252 K	188 K	258 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	95 K	218 K	-	374 K	506 K	1.6 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	86 K	-	340 K	202 K	162 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-33.3 M	-	-8.6 M	-7.97 M	-8.05 M	-	-8.53 M	-7.7 M	-8.6 M	-	-9.56 M	-9.41 M	-9.49 M	-	-8.25 M	-8.8 M	-8.07 M	-	-7.72 M	-6.55 M	-6.75 M	-	-7.13 M	-6.25 M	-7.8 M	-	-8.35 M	-6.69 M	-4.15 M	-	-3.11 M	-3.38 M	-2.57 M	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	73 K	-	17 K	22 K	97 K	-	165 K	190 K	206 K	-	281 K	35 K	41 K	-	79 K	112 K	156 K	-	-	12 K	-2 K	-	-	50 K	-1 K	-	41 K	-4 K	12 K	-	3 K	-146 K	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-33.1 M	-	-8.2 M	-7.57 M	-7.61 M	-	-8.03 M	-7.4 M	-8.42 M	-	-9.36 M	-9.21 M	-9.32 M	-	-8.05 M	-8.6 M	-7.87 M	-	-7.12 M	-5.95 M	-6.12 M	-	-6.53 M	-5 M	-7.18 M	-	-7.75 M	-6.09 M	-3.52 M	-	-2.31 M	-2.58 M	-1.81 M	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	8.53 M	7.7 M	8.6 M	-	9.56 M	9.41 M	9.49 M	-	8.25 M	8.8 M	8.07 M	-	7.72 M	6.55 M	6.75 M	-	7.13 M	6.25 M	7.8 M	-	8.35 M	6.78 M	4.37 M	-	3.48 M	3.89 M	4.17 M	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	2.94 M	-	2.52 M	2.96 M	2.81 M	-	2.7 M	2.77 M	3.08 M	-	3.07 M	2.77 M	2.87 M	-	2.35 M	2.27 M	2.26 M	-	2.04 M	2.19 M	2.12 M	-	2.01 M	1.95 M	2.18 M	-	1.72 M	1.78 M	1.3 M	-	894 K	1.13 M	1.18 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency